Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F-18 Florbetapir PET in Cardiac Amyloidosis
NCT01683825Phase 4Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2013
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Florbetapir in cardiac amyloidosis, sponsored by Brigham and Women's Hospital. Started Mar 2013; status: completed.
02
Drugs
Florbetapir
03
Conditions
cardiac amyloidosis
Beyond the preview
Go deeper on NCT01683825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01683825.